Blog articles

Cancer therapy involving genome editing cures another child’s leukaemia
We look at a new type of CAR-T cell therapy that, in the world’s first use, has cured a child patient’s leukaemia

Genomics on the horizon: Three predictions for 2023
To kick off the new year, we look at three areas of genomics research and advancement to watch out for in 2023 and beyond

How can genomics combat doxorubicin-induced cardiotoxicity?
This week, we examine the role that genomics could play in reducing the number of child cancer patients who experience doxorubicin-induced cardiotoxicity

Liquid biopsy: What is it and why does it matter?
We take a look at the blood test that researchers hope could lead to earlier diagnosis of cancer

The potential of polygenic risk scores for prostate cancer
We look at new research that introduces a genetic risk scoring system for the triage of prostate cancer patients in primary care

Bowel cancer: What role do our genes play?
We examine two genetically inherited syndromes that increase our risk of colorectal cancer

Detecting cancer predisposition: Finding the balance
This week, we weigh up the potential advantages and challenges of wider genomic testing for identifying cancer

Endometriosis and ovarian cancer: A genetic link
A new study aims to unravel the genomic connection between these two different health conditions

NHS launches sight-saving NIPT test
A new genomic test can identify babies at risk of a rare form of eye cancer with almost 100% accuracy

NHS launches sequencing pilot for glioblastoma
A new programme is bringing genomics-based personalised treatment to brain cancer patients for the first time

BRCA: beyond breast cancer
New evidence shows that BRCA variants may increase the risk of stomach and pancreatic cancers in both men and women
News articles

GeNotes featured in The Times
Our upcoming ‘just-in-time' educational resource hits the news on Rare Disease Day